The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.
 
Marleen Kok
Honoraria - Roche
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Leonie Voorwerk
No Relationships to Disclose
 
Hugo Horlings
No Relationships to Disclose
 
Karolina Sikorska
No Relationships to Disclose
 
Koen van der Vijver
No Relationships to Disclose
 
Maarten Slagter
No Relationships to Disclose
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
SuFey Ong
Employment - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Terry Wiersma
No Relationships to Disclose
 
Nicola Russell
No Relationships to Disclose
 
Ferry Lalezari
No Relationships to Disclose
 
Michiel de Maaker
No Relationships to Disclose
 
Inge Kemper
No Relationships to Disclose
 
Ingrid A. Mandjes
No Relationships to Disclose
 
Myriam Chalabi
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Roberto Salgado
Travel, Accommodations, Expenses - Roche; Roche
 
Sabine C. Linn
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); IBM (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - SC Linn is a named inventor on a patent for a BRCA1ness gene expression classifier in breast cancer (Inst)
Travel, Accommodations, Expenses - Roche
 
Ton Schumacher
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - AIMM Therapeutics; Kite, a Gilead company; Neon Therapeutics
Honoraria - AIMM Therapeutics; Neon Therapeutics
Research Funding - Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - -
 
Christian U. Blank
Stock and Other Ownership Interests - Verastem
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche